GoodRx Holdings (GDRX) Interest Expenses (2019 - 2026)

GoodRx Holdings' Interest Expenses history runs 8 years deep, the most recent figure standing at $9.8 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 8.24% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $41.7 million (down 14.71% YoY), while the FY2025 annual figure was $42.6 million, down 19.49% from the prior year.
• Interest Expenses came in at $9.8 million for Q1 2026 at GoodRx Holdings, down from $10.4 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $14.8 million in Q4 2023 to a low of $5.9 million in Q1 2022.
• A 5-year average of $11.5 million and a median of $11.4 million in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses soared 123.77% in 2023 and dropped 27.31% in 2025, its largest moves.
• GoodRx Holdings' Interest Expenses stood at $11.9 million in 2022, then climbed by 24.26% to $14.8 million in 2023, then fell by 23.37% to $11.4 million in 2024, then retreated by 8.41% to $10.4 million in 2025, then fell by 6.11% to $9.8 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $9.8 million, $10.4 million, and $10.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison